Concepedia

Michael E. Williams

ME

Statistics

Publications

65

Citations

6.4K

H-Index

33

Active since

1983

Affiliations

University of Virginia(Current)

University of Wisconsin–Madison

Dana-Farber Cancer Institute

Hackensack University Medical Center

Washington University in St. Louis

Michael E. Williams is an author at University of Virginia specializing in medicine, oncology, and molecular oncology.

ORCID

Publications per year

1983–2025

65

Publications

65

Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma

Michael Wang, Simon Rule, Peter Martin et al. · New England Journal of Medicine · 2013 · 1.7K citations · Full text

, , +17

Long-term follow-up of MCL patients treated with single-agent ibrutinib: updated safety and efficacy results

Michael Wang, Kristie A. Blum, Peter Martin et al. · Blood · 2015 · 402 citations · Full text

, , +10

Rituximab Infusion Promotes Rapid Complement Depletion and Acute CD20 Loss in Chronic Lymphocytic Leukemia

Adam D. Kennedy, Paul V. Beum, Michael D. Solga et al. · The Journal of Immunology · 2004 · 355 citations · Full text

, , +17

Postibrutinib outcomes in patients with mantle cell lymphoma

Peter Martin, Kami J. Maddocks, John P. Leonard et al. · Blood · 2016 · 283 citations · Full text

, , +8

P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential

Geoffrey Burnstock, Michael E. Williams · Journal of Pharmacology and Experimental Therapeutics · 2000 · 276 citations

, , +17

1–5 of 65